Several genes, including adiponutrin/patatin–like phospholipase domain–containing 3 and glucokinase regulatory protein, are known to be associated with both MetS and NAFLD (43). The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.